Aug 27, 2008Genmab Announces 2008 First Half Year Results
Conference Call:To join the conference call at 3:00 PM CEST / 9:00 AM EDT on August 28, please dial +1 877-795-3648 from inside the US or +1 719-325-4750 from outside the US.
Aug 25, 2008Genmab Announces Upcoming Ofatumumab Studies
Aug 21, 2008Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
Jul 31, 2008Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Jul 9, 2008Recruitment Completed In Ofatumumab CLL Front Line Study
Jun 30, 2008Genmab Reaches Milestone in Ofatumumab Collaboration
Jun 24, 2008Genmab Initiates Study of Zalutumumab with Radiotherapy in Head and Neck Cancer
Jun 10, 2008Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis
Jun 4, 2008Grant of Warrants in Genmab A/S
Jun 4, 2008Genmab to Attend Three June Investor Conferences
Jun 2, 2008Genmab Announces Appointment of David Eatwell as New Chief Financial Officer
May 30, 2008Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
May 29, 2008Genmab Announces Updates on Phase III Cancer Studies
May 28, 2008Genmab Announces 2008 First Quarter Results
May 6, 2008Genmab to Attend Two May Investor Conferences
Apr 30, 2008Genmab’s Total Number of Voting Rights and Total Share Capital
Apr 28, 2008Major Shareholder Announcement
Apr 24, 2008Constitution of the Board of Directors in Genmab and Grant of Warrants to Employees and a Member of Management
Apr 23, 2008Passing of Genmab A/S' Annual General Meeting
Apr 15, 2008Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
Apr 7, 2008Genmab A/S Summons Annual General Meeting
Apr 7, 2008Major Shareholder Announcement
Apr 1, 2008Capital Increase in Genmab as a Result of Employee Warrant Exercise
Mar 31, 2008Genmab Announces Year End 2007 Financial Results
Mar 13, 2008Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
Mar 3, 2008Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
Feb 27, 2008Genmab to Attend Two March Investor Conferences
Feb 26, 2008Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance
Feb 21, 2008Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
Feb 5, 2008Major Shareholder Announcement
Feb 4, 2008Major Shareholder Announcement
Jan 31, 2008Genmab’s Financial Calendar for 2008
Jan 30, 2008Major Shareholder Announcement
Jan 29, 2008Genmab to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 21, 2008Genmab Reaches Milestones in Ofatumumab Collaboration
Jan 4, 2008Genmab Announces HuMax-CD32b Pre-Clinical Program
Jan 3, 2008Genmab to Present at the 26th Annual JPMorgan Healthcare Conference